发育性髋关节发育不良患儿髋部手术中髂筋膜囊周围神经阻滞围术期镇痛的有效性与安全性:随机双盲非劣效试验的研究方案
本研究为单中心、前瞻性、随机双盲非劣效试验,拟纳入48例6个月至7岁拟行发育性髋关节发育不良髋部手术的患儿,随机分为髂筋膜囊周围神经阻滞组与骶管阻滞组,比较术后24小时内最高FLACC评分等指标,以评估髂筋膜囊周围神经阻滞的镇痛效果是否非劣效于骶管阻滞。
要点
- 拟纳入48例6个月至7岁发育性髋关节发育不良髋部手术患儿,随机分入髂筋膜囊周围神经阻滞组或骶管阻滞组。
- 主要结局为术后24小时内最高FLACC评分,用于非劣效性比较。
- 次要结局包括术中阿片类药物用量、术后24小时镇痛药用量、首次补救镇痛时间等。
核心结论
- 研究者预期本试验可提供证据表明髂筋膜囊周围神经阻滞对接受开放性髋部手术的患儿围术期镇痛安全有效。
研究设计与样本
- 单中心、前瞻性、随机双盲非劣效试验,拟纳入48例6个月至7岁拟行发育性髋关节发育不良髋部手术的患儿。
- 全身麻醉后行区域阻滞,使用0.25%罗哌卡因,剂量2.5 mg·kg-1,肾上腺素浓度1:200,000,随机分入髂筋膜囊周围神经阻滞组或骶管阻滞组。
- 主要结局为术后24小时内最高FLACC评分;次要结局包括术中阿片类药物用量、术后24小时内镇痛药用量、首次补救镇痛时间、PCA泵激活次数、SLIPA拔除时间、区域阻滞操作时长、不良事件发生率、罗哌卡因血浆浓度、住院时间和费用。
- 所有数据由设盲研究者收集,最终结果将在同行评审科学期刊发表。
- 试验注册:中国临床试验注册中心ChiCTR2100053128,注册日期2021年11月12日。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Surgical intervention is critical in the treatment of hip developmental dysplasia in children. Perioperative analgesia, usually based on high opioid dosages, is frequently used in these patients. In some circumstances, regional anesthetic procedures such as caudal block and lumbar plexus block have also been used. Previous research has shown that pericapsular nerve group (PENG) block provides excellent anesthetic efficacy during open hip surgery in adults. PENG block is thought to provide a similar analgesia effect comparable to caudal block. METHODS: This study is a single-center, prospective, randomized, double-blinded, non-inferiority experiment that enrolled children aged 6 months to 7 years who were scheduled for developmental dysplasia hip surgery. Following general anesthesia and regional blocks (0.25% ropivacaine at a dose of 2.5 mg·kg-1 with epinephrine at a concentration of 1:200,000), 48 individuals will be randomly assigned to either the PENG or caudal groups. The primary outcome measure is the highest FLACC (face, legs, activity, crying, consolability) score achieved within 24 h of surgery. Secondary outcomes include intraoperative opioid consumption, analgesic dosage within 24 h of surgery, time to start rescue analgesia, number of PCA pump activations, time to remove SLIPA (streamlined liner of the pharynx airway), duration of regional block procedures, incidence of adverse events, plasma ropivacaine concentrations, and hospital stays and costs. All data will be collected by blinded investigators. The trial's final results will be published in a peer-reviewed scientific journal. DISCUSSION: We expect this trial to provide some evidences that PENG block is safe and effective for perioperative analgesia in pediatric patients undergoing open hip surgery. TRIAL REGISTRATION: Chinese Clinical Trial Registry ChiCTR2100053128. Registered on November 12, 2021.
引用
- Xu M, He Y, Li Z, et al. Efficacy and safety of perioperative analgesia in PENG block for children undergoing hip surgery with developmental dysplasia: study protocol for a randomized, double-blinded, non-inferiority trial. Trials. 2025. PMID: 39825441. doi:10.1186/s13063-025-08725-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。